Latest news, reports, and more from the RedChip Nation.
 
Discovering Tomorrow's Blue Chips Today
November 19, 2021     Contact    
Featured This Week
 
SPI Energy (Nasdaq: SPI) Reports Net Sales Up 41% Year-Over-Year to $79.4 million in First Half of 2021
 

 


SPI Energy (Nasdaq: SPI), a global renewable energy company and provider of solar storage and electric vehicle (EV) solutions for business, residential, government, logistics and utility customers, reported revenue up 41% to $79.4 million in the first half of 2021, with gross profit increasing 134% to $7.4 million.


"Our team continues to perform extremely well across all of our business lines," stated Mr. Xiaofeng Denton Peng, Chairman & Chief Executive Officer of SPI Energy. "We are still in the early days of multiple significant market opportunities and believe we are in a great position to accelerate growth as we continue to expand our solar operations and scale our EV production across a growing line of innovative solutions."

 
 >
Latest News
 
Nano Dimension (NASDAQ: NNDM) Announces New DragonFly IV 3D-Printer and FLIGHT Software Package
 >
Recruiter.com (NASDAQ: RCRT) Announces Results of Recruiter Index for October 2021
 >
Borqs Technologies (NASDAQ: BRQS) is Granted Land Use Rights for 5G/IoT and Electric Vehicle Development
 
 
1847 Holdings (OTCQB: EFSH) Declares Quarterly Dividend
 
 
EVmo (OTC: YAYO) Launches Industry First Integrated Gig Delivery Technology Platform
 
 
Draganfly (NASDAQ: DPRO) ) Announces Record Third Quarter Revenue
 
 
Draganfly’s (NASDAQ: DPRO) Vital Intelligence AI Selected by The Franklin County Sheriff’s Office
 
 
Bragg (NASDAQ: BRAG) Secures Exclusive Five-Year Content Licensing Agreement with Bluberi
 
 
Bragg Gaming Group (NASDAQ: BRAG) 2021 Third Quarter Revenue Rises 9.9%
 
 
Lantern Pharma (NASDAQ: LTRN) Announces Abstract on Effectiveness of LP-184 in Glioblastoma Accepted for Presentation at the Society for Neuro-Oncology 2021 Annual Meeting
 
 
Lantern Pharma (NASDAQ: LTRN) to Host Virtual KOL Event on the Potential Treatment of Pancreatic Cancer with Drug Candidate LP-184 on November 18th, World Pancreatic Cancer Day
 
 
Greenwich LifeSciences (NASDAQ: GLSI) Provides Clinical Update on Upcoming Phase III Clinical Trial, FLAMINGO-01
 
 
Greenwich LifeSciences (NASDAQ: GLSI) Announces Acceptance of Two Posters at Upcoming 2021 SABCS Breast Cancer Conference
 
 
Greenwich LifeSciences (NASDAQ: GLSI) Provides Updated Corporate Presentation and Webcasts
 
 
Virios Therapeutics (NASDAQ: VIRI) Announces Third Quarter 2021 Financial Results and Provides Corporate Update
 
 
Cidara (NASDAQ: CDTX) Provides Corporate Update and Reports Third Quarter 2021 Financial Results
 
 
Aridis Pharmaceuticals (NASDAQ: ARDS) Announces Third Quarter 2021 Results
 
 
NETSOL Technologies (NASDAQ: NTWK) Reports Fiscal First Quarter 2022 Financial Results
 
 
Esports Entertainment Group (NASDAQ: GMBL) Announces Pricing of $8.0 Million Public Offering of 10.0% Series A Cumulative Redeemable Convertible Preferred Stock
 
 
BTCS (NASDAQ: BTCS) Reports Q3 2021 Financial Results
 
 
Hut 8 (NASDAQ: HUT) Achieves Third Consecutive Record-Breaking Quarterly Revenue in Q3-2021; Surpasses 5,000 Bitcoin Held in Reserve
 
 
DeFi Technologies (OTC: DEFTF) Files Form 40-F with the SEC in Anticipation of Nasdaq Listing
 
 
DeFi Technologies (OTC: DEFTF) Wholly Owned Subsidiary, Reaches Record US$374 Million in Assets Under Management
 
 
Everything Blockchain (OTC: OBTX) Announces Shareholder Call to Discuss Record Breaking Financial Performance
 
 
CBD of Denver (OTC: CBDD) Reports Year-to-Date Revenue of $22.6 Million
 
 
cbdMD, Inc. (NYSE American: YCBD) Extends Partnership with Spotify and Joe Rogan as Exclusive CBD Advertiser
 
 
 
Upcoming Zoom Webinar
 

Join Zoom Meeting: zoom.us/j/86300707880
One tap mobile :
US: +13017158592,,85211175789#,,,,*359084# or +13126266799,,85211175789#,,,,*359084#
Telephone: Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 852 1117 5789
Passcode: 359084
International numbers available:
zoom.us/u/kbEE4NSXZc


 
 
 

Join Zoom Meeting: zoom.us/j/84343965845
One tap mobile :
US: +13126266799,,84343965845# or +16465588656,,84343965845#
Telephone: Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 843 4396 5845
International numbers available:
zoom.us/u/kdv4WLYuPk


 
 
 
 
 
 
 
Quote of the Week
 
"Invest in something you can get your arms around and be very conservative, own enough stock so that you are not putting all your eggs in one basket."
- Dave Maley, Manager of Ariel Microcap Funds-Microcap Superstar
 
 
 
Lesson of the Week
 
The benefits of dollar-cost-averaging for the long-term investor.
Read More
 
 
 

 

Latest Videos
 
 
This week on RedChip TV: 3 Innovative Companies Using Technology to Transform Healthcare
 
This week’s episode of the RedChip Money Report features interviews with senior executives from Marpai (NASDAQ: MRAI), G Medical Innovations (NASDAQ: GMVD), and Lantern Pharma (NASDAQ: LTRN). Learn more at RedChip.com.
 
Watch Now
 
 
 
 
Nutriband: Pipeline of Innovative Transdermal Treatment Technologies
 
Nutriband (Nasdaq: NTRB) is a transdermal focused pharmaceutical company based in the United States with a goal to improve the safety, comfort and efficacy of existing drugs using transdermal technologies, benefitting patients, physicians, and payers.
 
Watch Now
 
 
 
 
Hut 8: High Growth, High-Margin Crypto Mining Stock
 
Hut 8 (Nasdaq: HUT) is one of North America's largest innovation-focused digital asset miners, supporting open and decentralized systems since 2018. Located in energy rich Alberta, Canada, Hut 8 has one of the highest installed capacity rates in the industry and holds more self-mined Bitcoin than any crypto miner or publicly traded company globally.
 
Watch Now
 
 
 
 
Lantern Pharma: Accelerating Cancer Drug Development Using AI
 
Lantern Pharma (Nasdaq: LTRN) is a clinical stage oncology-focused company who is harnessing the power of Artificial Intelligence and Genomics to develop precision cancer therapies. By leveraging RADR®, Lantern's proprietary big data engine, more effective cancer treatments can be developed and delivered to the right group of patients at a faster rate and for a fraction of the cost.
 
Watch Now
 
 
 
 
G Medical Innovations: Improving Patient Care with Innovative Medical Technologies
 
G Medical Innovations Holdings (Nasdaq: GMVD) is a commercial stage healthcare company engaged in the development of mobile health (or mHealth) and telemedicine solutions and monitoring service platforms. The Company is developing mobile technologies and services that are designed to allow consumers, patients, and providers to monitor, manage, and improve clinical and personal health outcomes.
 
Watch Now
 
 
 
 
Marpai: Revolutionizing Health Plan Administration
 
Marpai (NASDAQ: MRAI) is an AI-driven health tech company transforming third party administration (TPA) in the self-funded market by deploying deep learning, the most advanced artificial intelligence, to radically reduce costs, improve lives and simplify everything.
 
Watch Now
 
 
 
 
McLovins Growing High Quality Pet Care Pet Business
 
Caduceus Software Systems Corp (OTC: CSOC) is a Wyoming-based holding company with is wholly owned subsidiary McLovin's, a Pet Food and Pet Care company. The Pet Food and Pet Care market size was USD 207 Billion in 2020 with a stellar growth of 28.11%. The industry is expected to grow to USD 325 Billion in 2028 at a CAGR of 5.6%.
 
Watch Now
 
 
 
 
DSS: Multinational Operations in High-Growth Sectors
 
DSS, Inc. (NYSE American: DSS) is a multinational company operating business segments in blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets. Its business model is based on a distribution sharing system in which shareholders receive shares in its subsidiaries as DSS strategically unlocks value through IPO spin offs.
 
Watch Now
 
 
 
 
NETSOL: High-Growth Global FinTech & IT Solutions Provider
 
NETSOL Technologies (Nasdaq: NTWK) is a global fintech and IT company with domain expertise in leasing and financing industries. The Company's suite of applications are backed by 40 years of domain expertise and supported by a committed team of 1300+ professionals placed in eight strategically located support and delivery centers throughout the world.
 
Watch Now
 
 
 
 
Nynja: World’s First Real-Time Collaboration and Payment Platform
 
Nynja was designed to address the frustration of having to use multiple apps to communicate and share documents with teams, clients, and business partners. With Nynja, users can message, call, video conference and share files all in one place, from their mobile device or desktop all while offering unique, real-time translation and transcription features that make it faster and easier to do business and send payments around the globe without regard to borders.
 
Watch Now
 
 
 
 
DeFi Technologies: Transforming Global Finance
 
DeFi Technologies (OTC: DEFTF) builds and manages assets in the rapidly emerging decentralized financial market, providing institutional and retail investors easy access to previously unseen returns through innovative projects and groundbreaking protocols that are fundamentally reshaping the global financial system.
 
Watch Now
 
 
 
 
Cidara Therapeutics: Major Partnerships & Phase 3 Studies Underway
 
Cidara (Nasdaq: CDTX) is developing long-acting therapeutics designed to improve the standard of care for patients facing serious diseases. The Company’s portfolio is comprised of new approaches aimed at transforming existing treatment and prevention paradigms, first with its lead Phase 3 antifungal candidate, rezafungin, in addition to drug-Fc conjugates (DFCs) targeting viral and oncology diseases from Cidara’s proprietary Cloudbreak® platform.
 
Watch Now
 
 
 
 
Aptorum Group: Robust Development Pipeline Targeting Multiple Indications
 
Aptorum Group (Nasdaq: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum's current drug pipeline includes indications in orphan diseases, infectious diseases, and metabolic diseases. In 2021, the company plans to bring two candidates to clinical trials.
 
Watch Now
 
 
 
 
Genetic Technologies: Commercializing Game-Changing Disease Risk Tests
 
Genetic Technologies (Nasdaq: GENE) is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health.
 
Watch Now
 
 
 
 
Nano Dimension: Transforming Electronics Manufacturing
 
Nano Dimension (Nasdaq: NNDM) is transforming the electronics and similar additive manufacturing sectors into an environmentally friendly & economically efficient additive manufacturing Industry 4.0 solution, while enabling a one-production-step-conversion of digital designs into functioning devices - on demand, anytime, anywhere.
 
Watch Now
 
 
 
 
Order Small Stocks, Big Money Today!
 
Dave Gentry is the author of Small Stocks, Big Money: Interviews With Microcap Superstars. Published by Wiley, this first-hand perspective on the fast world of microcap investing is now available for purchase.
 
 
MidSouth Week in Review
 
The S&P recorded its longest streak of consecutive up days since 1997, up eight days in a row through last Monday.
Read More
 
 
 
 
About RedChip
 
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on small-cap and mid-cap companies. Since 1992, RedChip has delivered concrete, measurable results for its clients through the most comprehensive service platform in the industry for small-cap and mid-cap companies. These services include a worldwide distribution network for its stock research written by analysts holding the CFA designation; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated over 2.3 million unique investor views; quarterly global online institutional and retail investor conferences that reach over 10,000 investors annually; "The RedChip Money Report" television show which airs in 100 million homes across the U.S. on The Family Channel; a weekly newsletter delivered to 60,000 investors; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.
 
RedChip Disclosure
 
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the RedChip Companies Inc. is an investor relations firm hired by certain Companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and view RedChip’s Disclosures.
 
 
     
 
 
Copyright © 2021 RedChip Companies, Inc. All Rights Reserved.
You are receiving this message because this email address has signed up to receive News Alerts.